These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24253664)

  • 1. Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells.
    Wei X; Wang G; Li W; Hu X; Huang Q; Xu K; Lou W; Wu J; Liang C; Lou Q; Qian C; Liu L
    Oncol Rep; 2014 Jan; 31(1):335-41. PubMed ID: 24253664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma.
    Cui Q; Jiang W; Wang Y; Lv C; Luo J; Zhang W; Lin F; Yin Y; Cai R; Wei P; Qian C
    Hepatology; 2008 Jan; 47(1):105-12. PubMed ID: 17935223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.
    Xue X; Jungles K; Onder G; Samhoun J; Győrffy B; Hardiman KM
    Oncotarget; 2016 Mar; 7(10):11567-79. PubMed ID: 26871465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review).
    Wang SW; Sun YM
    Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway.
    Che S; Sun T; Wang J; Jiao Y; Wang C; Meng Q; Qi W; Yan Z
    Tumour Biol; 2015 Sep; 36(9):6805-11. PubMed ID: 25840690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
    Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
    Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway.
    Wang H; Fu Y
    BMC Cancer; 2021 Jul; 21(1):871. PubMed ID: 34330232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway.
    Wang SW; Hu J; Guo QH; Zhao Y; Cheng JJ; Zhang DS; Fei Q; Li J; Sun YM
    Oncol Rep; 2014 Nov; 32(5):1991-8. PubMed ID: 25216185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma.
    Liu L; Li W; Wei X; Cui Q; Lou W; Wang G; Hu X; Qian C
    Gene Ther; 2013 Jan; 20(1):84-92. PubMed ID: 22318090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.
    Zhang L; Yang Z; Ma A; Qu Y; Xia S; Xu D; Ge C; Qiu B; Xia Q; Li J; Liu Y
    Hepatology; 2014 Jan; 59(1):178-89. PubMed ID: 23897841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
    Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
    Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Rhizoma paridis total saponins on apoptosis of colorectal cancer cells and imbalance of the JAK/STAT3 molecular pathway induced by IL-6 suppression.
    Teng WJ; Chen P; Zhu FY; Di K; Zhou C; Zhuang J; Cao XJ; Yang J; Deng LJ; Sun CG
    Genet Mol Res; 2015 May; 14(2):5793-803. PubMed ID: 26125778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
    Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
    Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.
    Liu L; Nam S; Tian Y; Yang F; Wu J; Wang Y; Scuto A; Polychronopoulos P; Magiatis P; Skaltsounis L; Jove R
    Cancer Res; 2011 Jun; 71(11):3972-9. PubMed ID: 21610112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3.
    Shen A; Chen Y; Hong F; Lin J; Wei L; Hong Z; Sferra TJ; Peng J
    Oncol Rep; 2012 Dec; 28(6):2125-30. PubMed ID: 23027374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells.
    Wang Y; Ma X; Yan S; Shen S; Zhu H; Gu Y; Wang H; Qin G; Yu Q
    Cancer Res; 2009 Sep; 69(18):7302-10. PubMed ID: 19706767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Lu J; Zhang L; Zhou H; Du Z; Zhang G
    Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.